Creating treatments for Marburg virus infections
Development of Therapeutic Products for Marburg Virus
This study is working on a new treatment for people infected with the Marburg virus, aiming to improve their recovery and safety through careful testing and development.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Integrated Biotherapeutics, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project ID | NIH-10455345 on NIH RePORTER |
What this research studies
This research focuses on developing a new therapeutic product aimed at treating infections caused by the Marburg virus, which is a serious emerging infectious disease. The project involves several stages, including preclinical testing, optimizing the chemistry of the therapeutic, and ensuring that it can be manufactured safely and effectively. Patients may benefit from this research as it seeks to establish a treatment that could improve outcomes for those affected by this virus. The research will also assess the safety and efficacy of the therapeutic in early-stage clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals who are at risk of or have been diagnosed with Marburg virus infections.
Not a fit: Patients with other viral infections or those not affected by the Marburg virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for patients infected with the Marburg virus, potentially saving lives.
How similar studies have performed: While research on Marburg virus treatments is limited, similar approaches for other emerging infectious diseases have shown promise in developing effective therapies.
Where this research is happening
Rockville, United States
- Integrated Biotherapeutics, INC. — Rockville, United States (Active)
Researchers
- Principal investigator: Aman, M Javad — Integrated Biotherapeutics, INC.
- Study coordinator: Aman, M Javad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.